Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.2.727

Primary Central Nervous System Lymphoma: A Clinicopathological and Cytomorpholgical Study from A Tertiary Care Centre in Chennai, India  

Ambroise, M. Moses (Department of Pathology, PIMS, Puducherry, Apollo Speciality Hospital)
Ghosh, Mitra (Department of Histopathology, Apollo Speciality Hospital)
Mallikarjuna, V.S. (Department of Histopathology, Apollo Speciality Hospital)
Annapurneswari, S. (Department of Histopathology, Apollo Speciality Hospital)
Kurian, Ann (Department of Histopathology, Apollo Speciality Hospital)
Chakravarthy, Ranjani (Department of Histopathology, Apollo Speciality Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.2, 2013 , pp. 727-731 More about this Journal
Abstract
Background: The aim of this study was to analyze the clinicopathological and immunohistochemical features of primary central nervous system lymphoma (PCNSL) cases occurring in Indian patients and also study the utility of the crush smear preparation in intraoperative diagnosis. Materials and Methods: The immune status, clinical, radiological details, immunohistochemical profile, histopathological findings and cytological features in smear preparation of 32 cases of PCNSL were analyzed. Patients with systemic NHL and skull-base lymphomas were excluded. Results: The mean age of our patients was 52 years with a male: female ratio 1:1. A periventricular location was found in 62.5% of patients. None of our PCNSL cases were associated with AIDS. All cases except one were diffuse large B-cell lymphomas. Intraoperative diagnosis using crush smears allowed correct prediction in 93% of cases. Conclusions: Our study shows that PCNSL is seen predominantly in immunocompetent patients in India. The age of presentation is relatively young as compared to the West. Our study also stresses the utility of crush smear preparation in establishing an intraoperative diagnosis.
Keywords
Primary central nervous system lymphoma; brain tumor; immunohistochemistry; intraoperative diagnosis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Bataille B, Delwail V, Menet E, et al (2000). Primary intracerebral malignant lymphoma: Report of 248 cases. J Neurosurg, 92, 261-6.   DOI   ScienceOn
2 Buhring U, Herrlinger U, Krings T, et al (2001). MRI features of primary central nervous system lymphomas at presentation. Neurology, 57, 393-6.   DOI   ScienceOn
3 Bessell EM, Dickinson P, Dickinson S, Salmon J (2011). Increasing age at diagnosis and worsening renal function in patients with primary central nervous system lymphoma. J Neurooncol, 104, 191-3.   DOI
4 Corn BW, Marcus SM, Topham A, Hauck W, Curran WJ Jr (1997). Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer, 79, 2409-13.   DOI   ScienceOn
5 Choi YL, Suh YL, Kim D, et al (2006). Malignant lymphoma of the central nervous system: difficult histologic diagnosis after glucocorticoid therapy prior to biopsy. Clin Neuropathol, 25, 29-36.
6 Dolecek TA, Propp JM, Stroup NE ,Kruchko C (2012). CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol, 14, 1-49.   DOI
7 Eichler AF, Batchelor TT (2006). Primary central nervous system lymphoma: presentation, diagnosis and staging. Neurosurg Focus, 21, 16.
8 Fine HA, Mayer RJ (1993). Primary central nervous system lymphoma. Ann Intern Med, 119, 1093-104.   DOI   ScienceOn
9 Fischer L, Martus P, Weller M ,et al (2008). Meningeal dissemination in primary CNS lymphoma: prospective evaluation of 282 patients. Neurology, 71, 1102-8.   DOI   ScienceOn
10 Geppert M, Ostertag CB, Seitz G, Kiessling M (1990). Glucocorticoid therapy obscures the diagnosis of cerebral lymphoma. Acta Neuropathol, 80, 629-34.   DOI
11 Goplen AK, Dunlop O, Liestol K, et al (1997). The impact of primary central nervous system lymphoma in AIDS patients: a population-based autopsy study from Oslo. J Acquir Immune Defic Syndr Hum Retrovirol, 14, 351-4.   DOI   ScienceOn
12 Gelabert-Gonzalez M, Castro Bouzas D, Serramito-Garcia R, Frieiro Dantas C, Aran Echabe E (2012). Primary central nervous system lymphoma. Neurologia, June 13 [Epub ahead of print].
13 Henry JM, Heffner RR Jr, Dillard SH, Earle KM, Davis RL (1974). Primary malignant lymphomas of the central nervous system. Cancer, 34, 1293-302.   DOI
14 Hayabuchi N, Shibamoto Y, Onizuka Y, et al (1999). Primary central nervous system lymphoma in Japan: a nationwide survey. Int J Radiat Oncol Biol Phys, 44, 265-72.   DOI   ScienceOn
15 Herrlinger U, Schabet M, Bitzer M, Petersen D, Krauseneck P (1999). Primary central nervous system lymphoma: from clinical presentation to diagnosis. J Neurooncol, 43, 219-26.   DOI   ScienceOn
16 Haldorsen IS, Krakenes J, Goplen AK, et al (2008). AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003. BMC Cancer, 8, 225   DOI   ScienceOn
17 Haldorsen IS, Krakenes J, Krossnes BK, Mella O, Espeland A (2009). CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989-2003. AJNR Am J Neuroradiol, 30, 744-51.   DOI   ScienceOn
18 Haldorsen IS, Espeland A, Larsson EM (2011). Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol, 32, 984-92.   DOI   ScienceOn
19 Johnson BA, Fram EK, Johnson PC, Jacobowitz R (1997). The variable MR appearance of primary lymphoma of the central nervous system: comparison with histopathologic features. AJNR Am J Neuroradiol, 18, 563-72.
20 Koeller KK, Smirniotopoulos JG, Jones RV (1997). Primary central nervous system lymphoma: Radiologic-pathologic correlation. Radiographics, 17, 1497-526.   DOI   ScienceOn
21 Kadan-Lottick NS, Skluzacek MC, Gurney JG (2002). Decreasing incidence rates of primary central nervous system lymphoma. Cancer, 95, 193-202.   DOI   ScienceOn
22 Kadoch C, Treseler P, Rubenstein JL (2006). Molecular pathogenesis of primary central nervous system lymphoma. Neurosurg Focus, 21, 1.
23 Loureiro C, Gill PS, Meyer PR, et al (1988). Autopsy findings in AIDS-related lymphoma. Cancer, 62, 735-9.   DOI
24 Lanjewar DN, Jain PP, Shetty CR (1998). Profile of central nervous system pathology in patients with AIDS: an autopsy study from India. AIDS, 12, 309-13.   DOI   ScienceOn
25 Newell ME, Hoy JF, Cooper SG, et al (2004). Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer, 100, 2627-36.   DOI   ScienceOn
26 Olson JE, Janney CA, Rao RD, et al (2002). The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer, 95, 1504-10.   DOI   ScienceOn
27 Plesec TP, Prayson RA (2007). Frozen section discrepancy in the evaluation of central nervous system tumors. Arch Pathol Lab Med, 131, 1532-40.
28 Porter AB, Giannini C, Kaufmann T, et al (2008). Primary central nervous system lymphoma can be histologically diagnosed after previous corticosteroid use: a pilot study to determine whether corticosteroids prevent the diagnosis of primary central nervous system lymphoma. Ann Neurol, 63, 662-7.   DOI   ScienceOn
29 Schabet M (1999). Epidemiology of primary CNS lymphoma. J Neurooncol, 43, 199-201.   DOI   ScienceOn
30 Pasricha S, Gupta A, Gawande J, Trivedi P, Patel D (2011). Primary central nervous system lymphoma: a study of clinicopathological features and trend in western India. Indian J Cancer, 48, 199-203.   DOI
31 Satishchandra P, Nalini A, Gourie-Devi M, et al (2000). Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96). Indian J Med Res, 111, 14-23.
32 Sarkar C, Sharma MC, Deb P, et al (2005). Primary central nervous system lymphoma - a hospital based study of incidence and clinicopathological features from India (1980-2003). J Neurooncol, 71, 199-204.   DOI
33 Shibamoto Y, Ogino H, Suzuki G, et al (2008). Primary central nervous system lymphoma in Japan: changes in clinical features, treatment, and prognosis during 1985-2004. Neuro Oncol, 10, 560-8.   DOI   ScienceOn
34 Schultz CJ, Bovi J (2010). Current management of primary central nervous system lymphoma. Int J Radiat Oncol Biol Phys, 76, 666-78.   DOI   ScienceOn
35 Shiels MS, Pfeiffer RM, Hall HI, et al (2011). Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA, 305, 1450-9.   DOI   ScienceOn
36 Sutherland T, Yap K, Liew E, et al (2012). Primary central nervous system lymphoma in immunocompetent patients: a retrospective review of MRI features. J Med Imaging Radiat Oncol, 56 , 295-301.   DOI   ScienceOn
37 Tilgner J, Herr M, Ostertag C, Volk B (2005). Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: intraoperative versus final diagnosis- influence of clinical factors. Neurosurgery, 56, 257-65.   DOI
38 Zhang D, Hu LB, Henning TD, et al (2010). MRI findings of primary CNS lymphoma in 26 immunocompetent patients. Korean J Radiol, 11, 269-77.   DOI   ScienceOn
39 Weller M (1999). Glucocorticoid treatment of primary CNS lymphoma. J Neurooncol, 43, 237-9.   DOI   ScienceOn
40 Yeole BB (2008). Trends in the Brain Cancer Incidence in India. Asian Pac J Cancer Prev, 9, 267-70.